Citizens Financial Group Inc. RI Invests $747,000 in The Cooper Companies, Inc. $COO

Citizens Financial Group Inc. RI acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 10,422 shares of the medical device company’s stock, valued at approximately $747,000.

Several other institutional investors have also modified their holdings of COO. Heartland Advisors Inc. acquired a new stake in Cooper Companies during the 4th quarter worth $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Cooper Companies by 6.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company’s stock valued at $34,224,000 after acquiring an additional 23,896 shares during the last quarter. Swedbank AB boosted its stake in Cooper Companies by 18.8% in the fourth quarter. Swedbank AB now owns 1,074,029 shares of the medical device company’s stock valued at $88,027,000 after acquiring an additional 170,000 shares in the last quarter. Capital International Inc. CA boosted its stake in Cooper Companies by 22.9% in the fourth quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock valued at $9,688,000 after acquiring an additional 22,054 shares in the last quarter. Finally, SEB Asset Management AB purchased a new position in shares of Cooper Companies during the first quarter worth about $22,823,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on COO shares. Needham & Company LLC cut their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. UBS Group started coverage on Cooper Companies in a research report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 target price for the company. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Finally, The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $76.73 on Thursday. The company has a 50-day simple moving average of $71.59 and a 200-day simple moving average of $71.16. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock has a market capitalization of $14.96 billion, a price-to-earnings ratio of 65.03, a PEG ratio of 1.98 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the firm earned $0.96 earnings per share. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.